Literature DB >> 23590031

Health-care associated infections in Thailand 2011.

Yong Rongrungruang1, Narumol Sawanpanyalert, Patcharin Chomdacha, Kunlayanee Surasarang, Natcha Wiruchkul, Kanchana Kachintorn, Peangpim Tantilipikara, Somwang Danchaivijitr.   

Abstract

OBJECTIVE: To study the recent trend of health-care associated infections (HAIs) across Thailand. MATERIAL AND
METHOD: Using the modified international HAI definitions, the investigators conducted a prospective, nationwide, multi-centered survey to determine a 1-day point-prevalence of HAIs among hospitalized patients in the 47 acute care, primary to tertiary hospitals in January 2011.
RESULTS: Of total 10,762 patients (female 50.6%, mean age 44.2 +/- 27.3 years) enrolled in the study, 780 had HAIs or the average prevalence of HAIs was 7.3% (range 2.8-8.5%). Highest rates of HAIs were found in other hospitals (other type of tertiary-care facilities), intensive care units and lower respiratory tracts when stratified by type of hospital, unit of service and site of HAIs, respectively. Gram negative bacteria remained predominant among etiologic agents causing HAIs, as in prior studies. Acinetobacter spp., however emerged as the most common organism. At the time of study, 49.3% of all patients received one or more antimicrobial agents. Among the patients with HAIs, cephalosporins were the most commonly used.
CONCLUSION: Recently, no significant change on nationwide prevalence and trend of HAIs in Thailand were demonstrated. Notably, Acinetobacter spp. emerged as the most common etiologic agents of HAIs.

Entities:  

Mesh:

Year:  2013        PMID: 23590031

Source DB:  PubMed          Journal:  J Med Assoc Thai        ISSN: 0125-2208


  3 in total

1.  Clinical outcomes of hospital-acquired infection with Acinetobacter nosocomialis and Acinetobacter pittii.

Authors:  Sarunyou Chusri; Virasakdi Chongsuvivatwong; Jesabel I Rivera; Kachornsakdi Silpapojakul; Kamonnut Singkhamanan; Edward McNeil; Yohei Doi
Journal:  Antimicrob Agents Chemother       Date:  2014-05-12       Impact factor: 5.191

2.  Implementation of global antimicrobial resistance surveillance system (GLASS) in patients with bacteremia.

Authors:  Rujipas Sirijatuphat; Kantarida Sripanidkulchai; Adhiratha Boonyasiri; Pinyo Rattanaumpawan; Orawan Supapueng; Pattarachai Kiratisin; Visanu Thamlikitkul
Journal:  PLoS One       Date:  2018-01-03       Impact factor: 3.240

3.  Effectiveness and safety of polymyxin B for the treatment of infections caused by extensively drug-resistant Gram-negative bacteria in Thailand.

Authors:  Thundon Ngamprasertchai; Adhiratha Boonyasiri; Lantharita Charoenpong; Sireethorn Nimitvilai; Narisorn Lorchirachoonkul; Luksame Wattanamongkonsil; Visanu Thamlikitkul
Journal:  Infect Drug Resist       Date:  2018-08-20       Impact factor: 4.003

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.